Predictions
Abivax S.A.
Start price
Target price
Perf. (%)
€30.50
28.06.21
28.06.21
€25.00
28.06.22
28.06.22
-16.39%
01.12.21
01.12.21
Future proof or reliable business model
Probably not worthwhile Investment
overvalued
Very low/no dividend yield expected
Valneva SE
Start price
Target price
Perf. (%)
€11.84
13.09.21
13.09.21
-
13.09.22
13.09.22
139.19%
29.11.21
29.11.21
Revenue growth >5% per year expected
Could be very worthwhile Investment >20% year
High valuation
Growths slower than the competition
Valneva SE
Start price
Target price
Perf. (%)
€21.24
15.11.21
15.11.21
€25.00
15.11.22
15.11.22
33.24%
27.11.21
27.11.21
Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business
Boiron S.A.
Start price
Target price
Perf. (%)
€38.55
13.04.21
13.04.21
€36.00
13.04.22
13.04.22
-1.30%
26.11.21
26.11.21
Could be worthwhile Investment >10% per year
Oncodesign S.A.
Start price
Target price
Perf. (%)
€10.08
09.10.21
09.10.21
€12.00
09.10.22
09.10.22
-20.04%
26.11.21
26.11.21
Could be worthwhile Investment >10% per year
Valneva SE
Start price
Target price
Perf. (%)
€24.38
25.11.21
25.11.21
€21.00
25.11.22
25.11.22
6.64%
26.11.21
26.11.21
Could be worthwhile Investment >10% per year
Very valuable balance sheet
Valneva SE
Start price
Target price
Perf. (%)
€11.24
20.07.21
20.07.21
€20.00
20.07.22
20.07.22
116.90%
25.11.21
25.11.21
Could be worthwhile Investment >10% per year
Very valuable balance sheet
Poxel S.A.
Start price
Target price
Perf. (%)
€5.86
07.10.21
07.10.21
€7.50
07.10.22
07.10.22
-8.28%
24.11.21
24.11.21
Could be worthwhile Investment >10% per year
Ramsay Générale de Santé SA
Start price
Target price
Perf. (%)
€18.45
20.05.21
20.05.21
-
20.05.22
20.05.22
21.95%
21.11.21
21.11.21
Theradiag S.A.
Start price
Target price
Perf. (%)
€2.71
20.11.20
20.11.20
€3.50
20.11.21
20.11.21
-46.16%
21.11.21
21.11.21
Could be worthwhile Investment >10% per year
Erytech Pharma S.A.
Start price
Target price
Perf. (%)
€2.24
17.11.21
17.11.21
€1.80
17.11.22
17.11.22
0.00%
19.11.21
19.11.21
Could be worthwhile Investment >10% per year
Erytech Pharma S.A.
Start price
Target price
Perf. (%)
€2.19
11.11.21
11.11.21
-
11.11.22
11.11.22
2.28%
17.11.21
17.11.21
Could be worthwhile Investment >10% per year
Innate Pharma
Start price
Target price
Perf. (%)
€4.10
15.11.20
15.11.20
€5.50
15.11.21
15.11.21
7.86%
16.11.21
16.11.21
Could be worthwhile Investment >10% per year
Valneva SE
Start price
Target price
Perf. (%)
€19.59
31.10.21
31.10.21
€30.00
31.10.22
31.10.22
8.63%
13.11.21
13.11.21
Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business
bioMerieux S.A.
Start price
Target price
Perf. (%)
€107.60
07.11.21
07.11.21
€100.00
07.11.22
07.11.22
-1.02%
08.11.21
08.11.21
Could be worthwhile Investment >10% per year
bioMerieux S.A.
Start price
Target price
Perf. (%)
€111.90
12.04.21
12.04.21
€120.00
12.04.22
12.04.22
-3.84%
07.11.21
07.11.21
Could be worthwhile Investment >10% per year
Virbac S.A.
Start price
Target price
Perf. (%)
€395.50
25.10.21
25.10.21
€480.00
25.10.22
25.10.22
1.52%
07.11.21
07.11.21
Could be worthwhile Investment >10% per year